Connect with us

Entertainment

Oprah Tackles Perception of Obesity Treatment as “Vanity” and Lack of Access: “How Do We Fix This?”

Published

on


In a follow-up to Winfrey’s ABC special, experts weighed in on issues like access to care and the importance of medical supervision around weight loss drugs like Ozempic and Wegovy.

The pervasive belief that weight loss injectables are simply vanity drugs, fueled by its widespread use among celebrities and social media personalities, was addressed head on in a follow-up segment to Monday night’s An Oprah Special: Shame, Blame and the Weight Loss Revolution now streaming on Hulu.

“It’s really important for us to understand responsible use and understand where these drugs are indicated, because we’re all on social media. You’ll hear type II diabetics, for example, say, ‘I can’t get my Ozempic because people just want to lose weight and it’s vanity,’ we know that that’s misinformation,” said Negelle Morris, a senior vice president for Novo Nordisk, which manufactures weight loss drugs Ozempic and Wegovy. “We do really advocate for appropriate use as they’re indicated.”

There are real issues with access to popular drugs like Ozempic, Wegovy, Mounjaro and Zepbound, however, which was the focus of After the Show: A Weight Loss Revolution, in which the conversation shifted from the emotional barriers to weight loss drug use discussed in Oprah Winfrey’s ABC special to the practical issues.

“How do we fix this?” Winfrey asked a panel of physician and pharmaceutical experts who admitted the answer is complex.

“We’re seeing an inequity at the basic and most simplistic way,” said, Dr. W. Scott Butsch, director of obesity medicine in the Bariatric and Metabolic Institute at the Cleveland Clinic. “People who need medications that are highly effective don’t have a chance of getting them.”

One reason for that is the surge in demand for weight loss injectables in the past year alone, given their reported efficacy. The other is the high out-of-pocket costs for such treatments which currently aren’t covered by insurance.

“We don’t think of the downstream effects of the benefits,” Butsch said, noting the positive trickle-down effects of reducing obesity, including less burden on the healthcare system overall. “We’re so fixated on the upfront costs. You see insurance companies not cover it, states not cover it, Medicare and Medicaid not cover it.

“If you don’t believe obesity is a disease and you’re running a policy plan, how are you going to convince your members who are making those decisions,” he asked, explaining insurance companies’ resistance to covering weight loss medications. “You’re going to say, ‘Why should we bother giving a drug to somebody who should just eat less?’”

It’s because of such ideologies that Morris is seeking a reframing of the way weight loss drugs are not only thought about but talked about.

“I don’t really like to say ‘weight loss medications’ because I think that a lot of people think of weight loss as something we’ve been doing all of these years without understanding the underlying disease,” she said, noting losing pounds isn’t the only important benefit of such drugs, as she pointed out there are more than 60 chronic conditions linked to obesity. “We’re talking about not only, how do we continue to drive obesity treatment? But also, how are we preventing obesity to begin with?”

In the midst of answering audience questions about dosing, side effects and the effectiveness of the current class of approved weight loss drugs on the market, Morris also emphasized the importance of medical supervision when considering treatment.

“Everyone who had story a today, their health history is different which is why we need specialists,” she said. “Make sure you’re talking to a doctor you can trust.”

Interest in this area is only expected to rise as experts teased what they consider to be the “new wave of innovation” in the space. Triple G, a drug currently undergoing clinical trials, has been shown to be able to reduce users’ weight by 25 percent in just 48 weeks, indicating medical treatments for obesity, which, despite the immediate interest experts noted have been in existence for the past 20 years, are certainly here to stay. The same may also be true of Winfrey’s interest in continuing discussions around such drugs.

“I hope this helps everybody see it in a different light and also helps you to spread the word about the shaming and the blaming,” she said, concluding the after show special.

“That’s what we’re trying to shift in the culture right now, and it’s not going to be this one show or the show we did on the ‘The State of Weight,’ it’s going to be a decade,” Winfrey added with one final declaration: “I need to do more shows.”

———————————————————————————————-



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Entertainment

Taraji P. Henson and Terrence Howard Have Empire Reunion With Fight Night

Published

on



Taraji P. Henson and Terrence Howard Have Empire Reunion With Fight Night



Source link

Continue Reading

Entertainment

Under $50 Hoop Earrings We’re Loving Now

Published

on


The products featured in this article are from brands available in NBCUniversal Checkout. E! makes a commission on purchases.

Hoop earrings are not just a trend; they’re a lifestyle.

Whether you’ve been wearing hoop earrings since you were a little girl (or boy!) or have just started rocking the iconic accessory in sterling silver or gold, it’s time to build out your hoop earrings wardrobe.

Hoop earrings can be as versatile as studs. This jewelry must-have comes in so many shapes, sizes, and widths that it can enhance any number of styles.

Our shopping editors love hoops so much that we’ve found the perfect pair for every occasion below, and they’re all under $50.

Shop thin, delicate hoops below. This accessory option adds a dainty touch to a daytime look, making it a great choice for the office or everyday wear.

You can always add some drama to your ensemble with a chunky hoop earring in a fun shape for an event or date night. We’ve found a ton of options below in a variety of your favorite metals.

Add texture to your look with a set of hoops beaded with pearls, studded with diamonds, or featuring other stone options. And you don’t even have to go big! There are plenty of huggie hoop options below that would look great alone or in an earring stack.

We’ve picked out hoops that fit every style and budget. Whether you’re into silver or gold, we’ve found the perfect pair just for you.

Plus, a lot of these options are hypoallergenic and made by brands that create rust and tarnish-resistant jewelry, so they’ll stay in your collection for the long haul.



Source link

Continue Reading

Entertainment

Michael Keaton Totally Forgot He Was in a Marvel Movie

Published

on

By


Michael Keaton has portrayed some of cinema’s most iconic characters, including Beetlejuice and Batman, so the actor should be forgiven for forgetting he played one of the best villains in a Marvel movie. Keaton made his MCU debut in Spider-Man: Homecoming as an updated version of the popular comic-book villain, the Vulture. The MCU’s Vulture harnessed alien technology from the Battle of New York (shown in The Avengers) to develop dangerous technology, as opposed to wearing a skin-tight bird suit.

While participating in the WIRED Autocomplete Interview, Michael Keaton reflected on his time in the MCU. At least, he tried to. The actor completely forgot he appeared in Spider-Man: Homecoming. Keaton said he was asked about the movie a few days prior, and had to look it up on Google to remember who he actually played. Keaton said:

“I just saw this shot the other day. That great shot in the car, where I’m looking in the mirror. Somebody was asking me a question about this and I actually couldn’t remember. I had to Google myself to figure out what the hell, what I was doing in that shot. And I’m Vulture, of course.”

Michael Keaton reprised the role during a brief cameo in the internet’s favorite movie, Morbius (sadly, he didn’t utter the iconic line “it’s Morbin’ time”). Keaton never showed his face in the scene, as Vulture wore his militaristic helmet when meeting Jared Leto’s vampiric character. The scene was intended to set up the Sinister Six in a future Sony/Marvel movie. However, this cameo has yet to be paid off as the Sony Spider-Verse is still in shambles following the release of Madame Web.

Michael Keaton Coolly Explains Why He’s the Best Batman

While Michael Keaton had a hard time remembering his villainous character from Spider-Man: Homecoming, there’s one superhero he’ll never forget playing. Keaton played Bruce Wayne in Tim Burton’s Batman, the movie that re-defined the character on the big screen, following Adam West’s lighthearted tenure. Keaton loves looking back on his time as The Dark Knight. He even quoted the famous line, “I’m Batman,” during a commencement speech at Kent State University in 2018. During the interview, Keaton was asked why his version of Batman is the best. Not mincing words, Keaton simply said:

During his time as Batman, Michael Keaton said he learned a valuable career lesson from his co-star, Michael Gough, who played Alfred. During production, Keaton was still in the early days of his career. He remembered asking Gough “Do you think actors get better as they get older?” Keaton never forgot his response:

“I’ll never forget, he said, ‘I think they just get more.’ I said, ‘What do you mean?’ He said, ‘You just get more of what you are, you know?’ Always stuck with me.”

Let’s see if Michael Gough’s theory is true as Michael Keaton returns to the screen this spooky season as Beetlejuice in Tim Burton’s long-awaited sequel. Beetlejuice Beetlejuice sees Keaton return as, once again, the juice gets loose. The movie also stars Winona Ryder and Catherine O’Hara, both reprising their roles from the original film, alongside newcomer Jenna Ortega.



Source link

Continue Reading
Advertisement

Trending

paribahis bahsegel bahsegel bahsegel bahsegel resmi adresi

Copyright © 2024 World Daily Info. Powered by Columba Ventures Co. Ltd.